The AChR+ EAMG model is naturally more dramatic than the typical gradual onset of MG in human patients, which could in part explain the strong up-regulation of the atrogenes MuRF1 and atrogin-1 as well as the denervation marker AChRγ. Here, FBXO32 is linked to myasthenia gravis.